Synergy Pharmaceuticals Announces SP-333 Data Presentation at the 17th Neurogastroenterology & Motility Scientific Meeting
9/17/2013 6:55:20 AM
Synergy Pharmaceuticals Inc. (Nasdaq: SGYP) today announced a poster presentation on SP-333, its next-generation guanylate cyclase-C (GC-C) agonist in development for the treatment of gastrointestinal (GI) conditions, will be featured at the 17th Neurogastroenterology & Motility Scientific Meeting being held September 20-22, 2013 at the Hyatt Regency Resort & Spa in Huntington Beach, California.
Help employers find you! Check out all the jobs and post your resume.
comments powered by